Stock Price
298.65
Daily Change
-6.05 -1.99%
Monthly
-17.96%
Yearly
-52.97%
Q1 Forecast
351.07

Novo Nordisk reported DKK118.72B in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Bausch Health Companies USD 21.74B 228M Jun/2025
Bristol-Myers Squibb USD 50.93B 1.22B Jun/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
Merck USD 41.37B 5.97B Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Novo Nordisk DKK 118.72B 61.75B Mar/2025
Novo Nordisk DKK 118.72B 15.94B Mar/2025
Pacira USD 376.72M 203.77M Sep/2025
Sanofi EUR 21.76B 530M Sep/2025
Supernus Pharmaceuticals USD 31.77M 531K Jun/2025